Work

Abstract A22: Cost effectiveness of second line Axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma

Year: 2022

Type: conference-abstract

Source: Blood Cancer Discovery

DOI: 10.1158/2643-3249.lymphoma22-a22

Authors: Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Lihua E. Budde, Alexey Danilov, Matthew Mei, Leslie Popplewell, Tanya Siddiqi, Jasmine Zain, Stephen Forman, Larry Kwak, Steven Rosen, Alex Herrera, Nikhil Thiruvengadam

Institutions: City Of Hope National Medical Center, University Medical Center of Princeton, St. Luke's University Health Network, Loma Linda University Medical Center, Loma Linda University

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4294771606

Cites:

Cited by:

Related to: 10